In the brain, radiationinduced apoptosis is largely mediated by p53. We used longitudinal magnetic resonance imaging in a mouse model to map radiationinduced changes in neuroanatomy and quantified the impact of knocking out p53. We observed mitigation of radiation-induced volume loss by p53 knockout 1 week after treatment, but this was not maintained to adulthood as a result of decreased growth.
Summary
In the brain, radiationinduced apoptosis is largely mediated by p53. We used longitudinal magnetic resonance imaging in a mouse model to map radiationinduced changes in neuroanatomy and quantified the impact of knocking out p53. We observed mitigation of radiation-induced volume loss by p53 knockout 1 week after treatment, but this was not maintained to adulthood as a result of decreased growth.
Purpose: Pediatric cranial radiation therapy results in lasting changes in brain structure. Though different facets of radiation response have been characterized, the relative contributions of each to altered development is unclear. We sought to determine the role of radiation-induced programmed cell death, as mediated by the Trp53 (p53) gene, on neuroanatomic development. Methods and Materials: Mice having a conditional knockout of p53 (p53KO) or wildtype p53 (WT) were irradiated with a whole-brain dose of 7 Gy (IR; n Z 30) or 0 Gy (sham; n Z 28) at 16 days of age. In vivo magnetic resonance imaging was performed before irradiation and at 4 time points after irradiation, until 3 months posttreatment, followed by ex vivo magnetic resonance imaging and immunohistochemistry. The role of p53 in development was assessed at 6 weeks of age in another group of untreated mice (n Z 37). Results: Neuroanatomic development in p53KO mice was normal. After cranial irradiation, alterations in neuroanatomy were detectable in WT mice and emerged through 2 stages: an early volume loss within 1 week and decreased growth through development. In many structures, the early volume loss was partially mitigated by p53KO. However, p53KO had a neutral or negative impact on growth; thus, p53KO did not widely improve volume at endpoint. Partial volume recovery was observed in the dentate gyrus and olfactory bulbs of p53KO-IR mice, with corresponding increases in neurogenesis compared with WT-IR mice. Conclusions: Although p53 is known to play an important role in mediating radiationinduced apoptosis, this is the first study to look at the cumulative effect of p53KO through Introduction Cranial radiation therapy is a major contributing factor to long-term neurocognitive sequelae in patients treated for primary and metastatic brain tumors. 1 In the pediatric population, this may include disruption of normal brain development, with radiation-induced impairments manifesting as reduced intelligence quotient, memory function, and processing speed. 2 These deficits in neurocognitive function have been found to correlate with neuroanatomic deficits quantified by magnetic resonance imaging (MRI), 3 which in turn have been recapitulated in mice. 4 Because MRI measurements provide in vivo wholebrain coverage, correlate with behavior, [5] [6] [7] and are applicable in both patients and mice, they are convenient for high-throughput experimental evaluations of outcome.
Cranial irradiation leads to a cascade of consequences affecting brain homeostasis: blood-brain barrier disruption, cell death, chronic inflammation, demyelination, endothelial cell dysfunction, and impaired neurogenesis. 1 The contributions of each to altered brain development after radiation therapy in childhood has yet to be fully understood but could prioritize mitigation approaches most likely to yield clinical benefit for survivors of childhood cancer. Previous work from our laboratory has determined that neuroanatomic deficits emerge through 2 stages: an early widespread volume loss that is detectable within 1 week of irradiation and a longer-term deficit emerging as the result of slowed growth, almost exclusively in the olfactory bulbs (OBs). 8 Apoptosis (programmed cell death) occurs throughout the central nervous system (CNS) hours after irradiation. [9] [10] [11] [12] We hypothesized that apoptosis contributes significantly to the early volume deficit observed. Previous research has demonstrated that apoptosis of neurons, oligodendrocytes, and neural progenitor cells (NPCs) can be mediated through the ATM, ATR, and Trp53 (p53) genes. 9, 11, 13, 14 The aim of this study was to map the contribution of p53-mediated apoptosis to radiation-induced changes in brain development, as measured by MRI. For this purpose, we irradiated mice lacking p53 in many cells of the braindresulting from Cre expression under control of the human-Glial fibrillary acidic protein (GFAP) promoterdand compared volume outcomes to those of p53-wildtype mice.
Methods and Materials
Experimental procedures are outlined in the following sections, with additional details provided in Methods E1 (available online at https://dx.doi.org/10.1016/j.ijrobp. 2018.09.014).
Mice
Mice on a mixed C57BL/6J and 129 background bearing the Trp53 tm1Brn targeted mutation (p53 fl/fl ) were a gift from Dr Benjamin Alman's laboratory. Mice expressing Cre under control of the human-GFAP promoter were acquired from the Jackson Laboratory (FVB-Tg(GFAP-cre)25Mes/J, stock #4600). These human-GFAP-Cre mice express Cre in progenitor cells, resulting in widespread recombination at loxP sites and knockout of p53 when bred with p53 fl/fl mice. The gene knockout then affects all progeny, including many (but not all) neurons, oligodendrocytes, and astrocytes throughout the CNS with some variability by cell type and region. [15] [16] [17] [18] Mice were bred to produce littermates distinguished by p53 genotype: either lacking p53 (p53KO) in most brain cells because of conditional transcription of Cre under control of the human-GFAP promoter or retaining functional (floxed) p53 (WT) in Cre-negative animals. Mice of both genotypes were irradiated (p53KO-IR, n Z 16; WT-IR, n Z 14) or sham-treated (p53KO-sham, n Z 13; WT-sham, n Z 15) at 16 days of age, producing 4 experimental groups in total. A separate unhandled and unirradiated cohort (p53KO-U, n Z 17; WT-U, n Z 20) was used to evaluate possible genotype effects at 42 days of age by ex vivo MRI.
All 6 groups contained approximately equal numbers of male and female mice. All animal protocols were approved by the Centre for Phenogenomics Animal Care Committee.
Cranial irradiation
At 16 days of age, mice were anaesthetized with an intraperitoneal injection of ketamine and xylazine (75 and 5 mg/kg body weight, respectively). Irradiated mice were given a single dose of 7 Gy to the entire head at 0.75 Gy/min using a Cs-137 source (Gammacell 40 Extractor, Best Theratronics Ltd., Ottawa, Canada). 6 This is approximately equivalent to a clinically relevant dose of 16 Gy delivered in 2-Gy fractions. 19, 20 Lead-plate shielding was used to reduce the body dose to approximately 10% of the target dose (0.7 Gy). Sham-treated mice were anaesthetized but otherwise left to recover. 
Magnetic resonance image acquisition
All MRI scans were acquired on a 7T scanner (Direct Drive, Agilent Technologies). Structural in vivo MRI scans were acquired using a T1-weighted 3-dimensional gradient echo scan 21 at 14 (baseline), 23, 42, 63, and 98 days of age. To enhance neuroanatomic contrast, mice were injected intraperitoneally with MnCl 2 (0.4 mmol/kg, Sigma-Aldrich) 24 hours before each scan. During imaging, mice were anesthetized with a constant source of 1% isoflurane and scanned with multiple-mouse MRI using 7 unshielded saddle coils. Perfusion fixation was performed immediately after the final in vivo scan, as previously described. 22, 23 Briefly, this procedure consists of transcardiac perfusion with a phosphate-buffered saline (PBS), heparin, and ProHance (gadoteridol, Bracco Diagnostics, Princeton, NJ) solution followed by a PBS, Prohance, and methanol-free formaldehyde solution. Brain samples within the skull were soaked in the second solution for 24 hours before being transferred to a storage solution of PBS, ProHance, and NaN 3 . To acquire structural ex vivo scans, brain samples within the skull were imaged using a T2-weighted 3-dimensional fast spin echo sequence. 24 
Image analysis
Voxel volumes across all mice were calculated after a multistep registration process. 25 Volumes for anatomic structures were calculated using the MAGeT Brain algorithm, 26 with an input atlas containing 62 structures 27 or 180 structures [27] [28] [29] for the in vivo and ex vivo data, respectively. In vivo neuroanatomic volumes were fit with a linear mixed effects model, including random intercepts for each mouse and defining normal growth with a spline. 30, 31 A dose-and genotype-dependent deviation was modeled with coefficients for an intercept-offset and a slope linear in age. To probe individual postirradiation time points, the reference point of the age variable was adjusted so that the intercept-offset coefficients could be evaluated for differences between groups. Ex vivo neuroanatomic volume was fit with a linear regression model accounting for genotype, dose, and their interaction, as well as pretreatment brain volume where available. For both in vivo and ex vivo data, P values were corrected for multiple comparisons using the false discovery rate (FDR) method. 32 
Histopathology and immunohistochemistry
For quantification of apoptosis, samples from 3 additional p53KO-IR and WT-IR mice were prepared by perfusion fixation 7.5 hours after irradiation. Coronal sections containing the subventricular zone (SVZ) at the lateral ventricles, the dentate gyrus (DG), and corpus callosum were stained with either hematoxylin and eosin or Rip and 4,6-diamidino-2-phenylindole (DAPI). Apoptotic cells were identified by their characteristic nuclear condensation and fragmentation, 33 which has been shown to have an 85% concurrence with TUNEL or caspase 3. 34 Coronal sections containing the SVZ or the DG and corpus callosum were obtained from a minimum of 3 mice for each group perfused at 98 days of age. Doublecortin (DCX) and myelin basic protein immunohistochemistry (IHC) was performed with DAPI nuclear counterstaining. To test for significance, each IHC metric was fit with a linear regression model accounting for genotype, dose, and their interaction.
Results

Neuroanatomy in p53KO mice is normal
The p53 gene has been implicated in normal neuro-and gliogenesis. [35] [36] [37] [38] Nevertheless, we found no statistically significant differences in neuroanatomic volume attributable to genotype between 42-day-old p53KO-U and WT-U mice (Fig. 1A) . To assess the potential magnitude of undetected differences (if present), we performed a power analysis, as described in Methods E1 (available online at https://dx.doi.org/10.1016/j.ijrobp.2018.09. 014), and determined that our analysis was sensitive to volume differences of approximately 3% to 10% before correction for multiple comparisons (or 5%-15% after Bonferroni correction), depending on the specific structure ( Fig. 1B; Fig. E1A , available online at https:// dx.doi.org/10.1016/j.ijrobp.2018.09.014). Similar results were confirmed using the p53KO/WT-sham mice ( Fig. E1B ; available online at https://dx.doi.org/10.1016/ j.ijrobp.2018.09.014). We conclude that if there are differences in neuroanatomy in p53KO mice, these differences are smaller than 5% (Fig. 1C ).
Knockout of p53 decreases radiation-induced apoptosis
At 7.5 hours after irradiation, extensive apoptosis was seen in the subgranular zone (SGZ) of the DG (Fig. 2 indicating that knockout of p53 in these mice significantly decreases radiation-induced apoptosis.
Irradiation of wildtype mice results in an early volume difference and long-term growth deficit
We modeled longitudinal neuroanatomic growth using a linear mixed effects model. After administering 0 (sham) or 7 Gy to WT mice, there was a significant (FDR < 0.15) decrease in volume at the first postirradiation time point in 45 of the 62 structures evaluated (Fig. 3A, 3B ). Although this constituted most of the brain, the structures most significantly affected in this way were the OBs, the DG of the hippocampus, the cerebellum, and white matter structures. In only 2 regions, the OBs and the lateral olfactory tract, this volume loss was further followed by a decreased growth rate, resulting in an increasing volume deficit over time (Fig. 3A, 3C ). These findings recapitulated expectations from previous work. 6, 8 Postirradiation early volume difference is mitigated by absence of p53
To assess the effect of p53KO on radiation-induced changes in neuroanatomy and development, we fit longitudinal volume measurements in p53KO-IR, WT-IR, p53KO-sham, and WT-sham groups with a mixed effects model and tested for significant (15% FDR) dose-genotype interactions at each in vivo postirradiation time point. A benefit of p53KO, defined as having a significant positive dose-genotype interaction for at least 1 time point, was found in 9 of the 62 structures evaluated: the molecular and granular cell layers of the DG (Fig. 4A ), stria terminalis (Fig. 4B) , OBs, midbrain, cerebellar cortex, pons, optic tract, and internal capsule.
To determine whether the radiation-induced early volume deficit and decreased growth (Fig. 3A, 3B ) could be mitigated by p53KO, we tested for significance of dose-genotype interaction coefficients in the mixed effects model. Of the 9 structures showing an altered time course because of p53, significant mitigation of the early radiation-induced volume loss was detected in 6 ( Fig. 4E ). An example of this effect can be seen from a plot of mean stria terminalis volume at 23 days of age (Fig. 4B, 4C ). The only structure for which long-term growth was significantly negatively altered by p53KO was the stria terminalis ( Fig. 4D ). White matter structures (including the stria terminalis) had a trend toward decreased growth in p53KO-IR mice compared with WT-IR, whereas other structures had either stable growth or a trend toward increased growth (including the DG and OBs) ( Fig. 4F ). However, although the growth for some structures in p53KO-IR mice appeared improved compared with WT-IR, growth in most structures was neutral or decreased compared with p53KO-sham ( Fig. 4G) . Consequently, the volume improvements in p53KO-IR mice observed at 23 days of age were not sustained through early adulthood. An evaluation plotting volume change for all structures in the brain is provided in Figure E3 (available online at https://dx.doi.org/10. 1016/j.ijrobp.2018.09.014), which emphasizes the difference in the impact of p53KO on radiation-induced early volume loss and growth.
Analysis of the longitudinal data at the final time point (98 days of age) demonstrated that most of the brain remained negatively affected by irradiation ( Fig. 5A, 15%  FDR) . A positive impact by p53KO, determined from a significant dose-genotype interaction, was found in only 2 structures: the DG and the OBs (Fig. 5B ). High-resolution analysis of ex vivo data at the same time point identified only 2 structures, from an atlas of 180, that experienced a significant effect (15% FDR) of p53-KO after irradiation: the molecular layer and granular layer of the DG. From the voxelwise results it is apparent that, among the parts of the brain significantly affected by irradiation ( Fig. 5C ), the long-term benefit of p53KO is very localized (Fig. 5D ).
We found no significant impact of sex in the dose and dose-genotype interactions; therefore, coefficients accounting for this interaction were eliminated for the reported analyses.
Partial recovery of neuroblast production resulting from p53KO is detected at 98 days Irradiation of WT mice resulted in a significant loss in the number of DCX positive (þ) cells ( Fig. 6A-6F ) in both the SGZ of the DG (Fig. 6E ) and the SVZ (Fig. 6F ) (80% and 70% loss, respectively; P < .0001). This loss of neuroblasts was decreased, though not fully, in p53KO-IR mice in both the SGZ and SVZ (reducing loss to 47% and 26%, respectively; P < .05). There was no difference in neuroblast production in p53KO-sham mice compared with WT-sham (P ! .4).
Staining for myelin basic protein and quantification of fluorescence intensity in the corpus callosum and anterior commissure showed no significant differences ( Fig. E4 ; available online at https://dx.doi.org/10.1016/j.ijrobp.2018. 09.014).
Discussion
p53 plays both transcriptional and nontranscriptional roles within a complex network regulating cellular behavior and diverse biological functions. 39 Although p53 is widely regarded as a tumor suppressor that is frequently mutated in cancer, 40 it also plays important roles in the healthy cell during stress response, including cell-cycle arrest, senescence, and apoptosis. 39 This study characterized the role that p53 plays in neuroanatomic development after irradiation of the young brain. Specifically, we probed cells that express human-GFAP and their progeny, which includes late-gestation radial-glia and adult NPCs; astrocytes and oligodendrocytes throughout the brain and spinal cord; and neurons found in the hippocampus, cortex, and OBs. [15] [16] [17] [18] We have shown that p53KO rescues the brain from radiation-induced volume losses in the short term but that normal growth in p53KO-IR mice is subsequently hampered so that impairments are still observed by early adulthood. With the exception of the DG, none of the structures affected by irradiation exhibited completely normalized outcomes as a result of p53KO. Radiation-induced apoptosis occurs in many different cell types throughout the CNS, including cells in the external granule cell layer of the cerebellum, 9 oligodendrocytes, 10,11 and neuroblasts/immature neurons and NPCs of the subependyma and SGZ. 11, 12 With loss of Fig. 4 . Volume of the dentate gyrus of the hippocampus (A) and stria terminalis (B) with respect to age. Each timepoint with a significant positive dose-genotype interaction is marked with a star ()false discovery rate [FDR] <15%). Fixed effects from the mixed effects model were used to plot the fitted curve. Points and whiskers show mean structure volume and bootstrapped 95% confidence intervals, for each group, after removal of the fitted random effect terms in the mixed effects model. Zoomed in plots of the stria terminalis at 23 (C) and 98 (D) days of age show mitigation of the irradiation induced early volume difference (**P < .005; *P < .05) that is lost over time. This can be seen on the color maps (E, F, and G) for all structures with a significant (15% FDR) benefit. (E) The mitigation by p53 knockout (KO) of the early volume difference is presented as a volume difference between p53KO-IR and wildtype (WT)-IR mice at 23 days of age. In (F) and (G) the differences in the long-term effect on growth is presented as the volume acquired per week between the WT-IR and p53KO-IR and between p53KO-IR and WT-sham mice, respectively. Abbreviation: MB Z midbrain; IC Z internal capsule; DG Z dentate gyrus; OT Z optic tract; Cereb. Z cerebellum; OB Z olfactory bulb; IR Z irradiated with a whole-brain dose of 7 Gy.
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International Journal of Radiation Oncology Biology Physics p53 function, the apoptotic incidence is abrogated in these cell types. 8, 11, 41 Furthermore, a recent study demonstrated increased turnover of NPCs and neuroblasts in irradiated mice lacking p53 compared with wildtypes. 37 This may support improved volume maintenance in some regions in p53KO mice shortly after treatment. Consistent with these results, we have shown that early volume loss in the brain after irradiation can be mitigated by p53KO. Despite short-term benefits, there is evidence for long-term loss of neurogenesis and neural stem cell number in irradiated young adult mice lacking p53. 36, 37 This suggests that apoptosis is not the only mode of cell death, considering neural stem cells are resistant to radiation-induced apoptosis. 34, 42 Because p53 is a key player in cell cycle arrest and DNA repair, increased cell division after irradiation or failure of p53 to repair the cell may lead to an increase in other forms of cell death, such as mitotic catastrophe. In addition, previous research has demonstrated that NPCs transplanted into the DG of irradiated mice, regardless of their p53 genotype status, still exhibit impaired neuronal differentiation, 37 implying that persistent extrinsic factors inhibit neurogenesis after irradiation, independent of apoptosis. This is consistent with our observation that growth in p53KO-IR mice is reduced. Nevertheless, our results demonstrate that sites requiring neurogenesis, notably the DG and the OBs, In vivo at 98 Days
Ex vivo at 98 Days
Effect of Irradiation
Mitigation by p53KO
Mitigation by p53KO Fig. 5. Structurewise (A, B) and voxelwise (C, D) volume differences at 98 days of age from in vivo and ex vivo imaging, respectively. Regions highlighted are those that are significantly (15% false discovery rate) smaller in volume as a result of irradiation (A, C) and where that difference because of irradiation is significantly mitigated by p53 knockout (B, D). exhibited significant improvements in p53KO mice compared with irradiated wildtype mice, highlighting the important impact of p53-mediated apoptosis in these regions.
In the unirradiated brain, absence of p53 has been reported to alter proliferation and differentiation profiles of NPCs and oligodendrocyte precursors. [35] [36] [37] [38] Despite this, we observed no significant effect of p53KO on normal neuroanatomic development. Because IHC provides only a snapshot of narrowly defined cellular activity, it is expected that volume measurements, sensitive to many kinds of change over the duration of the study, may not correlate unambiguously with these results. Nonetheless, we observed improved volumetric outcomes after irradiation in the DG and OBs as well as partially spared DCXþ neuroblast production. This highlights the important role that global MRI volume measures can play in providing longitudinal and brain-wide quantification of outcome.
It should be noted that most previous investigations of the role of p53 after radiation have used a traditional gene knockout in which p53 is removed from all cell types. This is different from our current study, wherein we used Cre-Lox recombination with mice expressing Cre under the human-GFAP promoter, limiting knockout almost exclusively to cells in the brain. 15 NPCs that transiently express this promoter give rise to high percentages of neurons in the dorsal telencephalon and oligodendrocytes and astrocytes throughout the CNS. 16, 18 According to Casper et al, 64% and 97% of NeuNþ neurons in the OBs and hippocampus, respectively, and 67% of APCþ oligodendrocytes in the corpus callosum are derived from this lineage. Because of late-gestation expression of human-GFAP in radial glia 15 higher percentages of cells in the ventral compared with the dorsal telencephalon develop from this lineage. [16] [17] [18] Recombination in astrocytes for this particular promoter may also be reduced, although interpretation depends on the marker used. 18 Furthermore, endothelial and microglial cells, for example, have distinct lineages from neurons, astrocytes, and oligodendrocytes and are not affected by our conditional knockout. Apoptosis after irradiation in some cells, such as endothelial cells, can also be mediated through pathways independent of p53. 36 The findings in this study must be interpreted in this context. Where there is a lack of significant improvement in irradiated p53KO mice, it is possible that retained p53 expression in some cells may influence the outcome. Nonetheless, the benefits from p53KO are noteworthy.
Conclusions
Overall our findings demonstrate that p53 plays an important role in mediating radiation-induced neuroanatomic changes throughout much of the brain in the early days after irradiation. Although p53 is important and detrimental in this process, it is also well established that p53 has beneficial functions in promoting DNA repair and regulating the cell cycle. Thus, manipulation of p53 seems an unlikely strategy for clinically relevant treatments. Rather, the experiments presented here indicate the extent to which radiation-induced apoptosis affects structural development of the brain. Thus, this work establishes the extent to which clinically feasible antiapoptotic treatments might normalize neuroanatomic development after cranial irradiation.
